Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
October 07, 2026 2.015
October 06, 2026 2.015
October 05, 2026 2.015
October 02, 2026 2.015
October 01, 2026 2.015
September 30, 2026 2.015
September 29, 2026 2.153
September 28, 2026 2.153
September 25, 2026 2.153
September 24, 2026 2.153
September 23, 2026 2.153
September 22, 2026 2.153
September 21, 2026 2.153
September 18, 2026 2.153
September 17, 2026 2.153
September 16, 2026 2.153
September 15, 2026 2.153
September 14, 2026 2.153
September 11, 2026 2.153
September 10, 2026 2.153
September 09, 2026 2.153
September 08, 2026 2.127
September 04, 2026 2.127
September 03, 2026 2.127
September 02, 2026 2.127
Date Value
September 01, 2026 2.127
August 31, 2026 2.127
August 28, 2026 2.127
August 27, 2026 2.186
August 26, 2026 2.186
August 25, 2026 2.186
August 24, 2026 2.186
August 21, 2026 2.186
August 20, 2026 2.186
August 19, 2026 2.186
August 18, 2026 2.186
August 17, 2026 2.186
August 14, 2026 2.186
August 13, 2026 2.192
August 12, 2026 2.192
August 11, 2026 2.192
August 10, 2026 2.277
August 07, 2026 2.277
August 06, 2026 2.277
August 05, 2026 2.277
August 04, 2026 2.277
August 03, 2026 2.277
July 31, 2026 2.277
July 30, 2026 2.244
July 29, 2026 2.244

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Pharma Mar SA 5.72
Grifols SA 0.7953
ACADIA Pharmaceuticals, Inc. 2.580
Alkermes Plc 3.814
Alnylam Pharmaceuticals, Inc. 21.91

Price to Book Value Related Metrics

Price 3.098
Earnings Yield -1.15%
Market Cap 240.11M